United States · FDA National Drug Code directory
sirolimus
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65841-771_7e6e294d-cf29-40e2-91e1-9693fdcd6b6c
- Product NDC
- 65841-771
- Form
- TABLET, FILM COATED
- Composition / generic term
- sirolimus
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140115
- Source listing expiry
- 20261231
Source-listed ingredients
- SIROLIMUS — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (65841-771-01) · 65841-771-01
- 500 TABLET, FILM COATED in 1 BOTTLE (65841-771-05) · 65841-771-05
- 30 TABLET, FILM COATED in 1 BOTTLE (65841-771-06) · 65841-771-06
- 1000 TABLET, FILM COATED in 1 BOTTLE (65841-771-10) · 65841-771-10
- 90 TABLET, FILM COATED in 1 BOTTLE (65841-771-16) · 65841-771-16
- 10 BLISTER PACK in 1 CARTON (65841-771-77) / 10 TABLET, FILM COATED in 1 BLISTER PACK (65841-771-30) · 65841-771-77
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →